Dwayne 'The Rock' Johnson TRT: Press Coverage and Statements

What Dwayne Johnson Has Actually Said About Steroids and TRT

Dwayne Johnson's only confirmed, on-record admission about performance-enhancing substances comes from a 2009 interview with ESPN The Magazine, in which he said he and a friend tried steroids for "about a half a year" at age 18. He described the experience as a mistake he would not repeat. No subsequent interview, podcast appearance, or verified social media post has included a direct statement confirming current TRT or HGH use.

The 2009 ESPN Admission

The ESPN interview remains the single primary-source document underpinning most press coverage. Johnson said: "We were young, we were naive, we were just stupid. We definitely learned our lesson." This language frames the use as adolescent experimentation. He was 18 in 1990, well before his professional wrestling and film careers.

Adolescent anabolic steroid use carries documented risks. A 2021 review in the Journal of Clinical Endocrinology and Metabolism found that supraphysiologic androgen exposure during puberty can suppress the hypothalamic-pituitary-gonadal (HPG) axis, potentially contributing to adult-onset hypogonadism in a subset of users 1. This is clinically relevant context, though it does not confirm Johnson's current hormonal status.

Subsequent Public Silence

Since 2009, Johnson has not expanded on the admission in any documented interview. His social media presence, spanning over 700 posts per year across Instagram and X, focuses on training footage, diet content, and film promotion. No post has referenced TRT, testosterone, or HGH protocols. Fitness journalists at outlets including Men's Health have asked adjacent questions in profile pieces; Johnson has declined to elaborate beyond the 2009 statement.

What Clinical Medicine Says About Men Johnson's Age and TRT

Johnson was born on May 2, 1972, making him 52 years old as of this article's publication. Late-onset hypogonadism becomes increasingly common in men over 45. The Endocrine Society's 2018 Clinical Practice Guideline on male hypogonadism states: "We recommend making the diagnosis of hypogonadism only in men with consistent symptoms and signs and unequivocally low serum testosterone concentrations." 2

Prevalence Data

Population data from the European Male Ageing Study (N=3,369) found that symptomatic late-onset hypogonadism affected roughly 2.1% of men aged 40 to 79, rising to 5.1% in men aged 70 to 79 3. A separate JAMA Internal Medicine analysis of U.S. Commercial insurance data estimated 2.9 million testosterone prescriptions were filled in 2020 alone 4. TRT is neither rare nor illicit when medically indicated.

Symptoms That Prompt Evaluation

Standard diagnostic criteria from the American Urological Association and Endocrine Society include total morning testosterone below 300 ng/dL on two separate measurements, combined with symptoms such as fatigue, reduced libido, decreased lean mass, or depressed mood 2. Whether Johnson meets these criteria is unknown because no blood panel data has been made public.

FDA-Approved TRT Options

The FDA has approved multiple testosterone formulations for male hypogonadism 5. These include:

• Testosterone cypionate injection (e.g., Depo-Testosterone), typically 100 to 200 mg every 1 to 2 weeks
• Testosterone enanthate injection, similar dosing range
• Topical testosterone gels (AndroGel 1%, 1.62%; Testim; Vogelxo)
• Testosterone pellets (Testopel), implanted subcutaneously every 3 to 6 months
• Testosterone undecanoate injection (Aveed), 750 mg intramuscularly at weeks 0, 4, then every 10 weeks

None of these require disclosure by private citizens. A 52-year-old male patient on any of these regimens would be acting within standard medical practice if he carries a valid prescription from a licensed physician.

The HGH Speculation: Evidence and Limits

Fitness media and several tabloid outlets have repeatedly suggested Johnson uses human growth hormone (HGH), citing his reported body composition and recovery capacity. This claim has no confirmed primary-source basis. Johnson has not addressed HGH use in any publicly documented interview.

What the Science Says About HGH

HGH prescribed as recombinant human growth hormone (rhGH, somatropin) is FDA-approved only for diagnosed adult growth hormone deficiency, short bowel syndrome, and HIV-associated wasting 6. Prescribing it for body composition or anti-aging purposes is off-label and legally restricted under the Anti-Drug Abuse Act of 1990.

A 2007 meta-analysis in Annals of Internal Medicine (N=220 across 31 trials) found rhGH increased lean body mass by 2.1 kg and reduced fat mass by 2.1 kg on average but produced no meaningful increase in strength or functional capacity in healthy adults without deficiency 7. The authors concluded the evidence did not support use in healthy adults. Adverse effects including fluid retention, arthralgia, carpal tunnel syndrome, and glucose intolerance were common.

Why Inference Is Unreliable

Attributing a specific physique to a specific compound without blood work or pharmacy records is not clinically valid. Factors including professional nutrition staff, structured periodization, sleep optimization, and anabolic training stimulus over 30+ years of consistent resistance training all contribute to muscular hypertrophy independent of exogenous hormones. The Endocrine Society notes that total testosterone levels within the normal range (300 to 1,000 ng/dL) already support lean mass maintenance in men who train 2.

How TRT Press Coverage Shapes Public Perception

Coverage of celebrities and TRT tends to follow a predictable pattern: physique observation, speculation, absence of denial read as implicit confirmation, and then repetition across outlets until the speculation is treated as established fact. This pattern applies to Johnson's coverage and misrepresents how TRT journalism should work.

The Confirmation Problem

Johnson has neither confirmed nor denied current TRT use. Journalistically and clinically, these are not equivalent positions. The burden of evidence for a factual claim lies with those asserting it. No outlet has published lab values, pharmacy records, or physician statements related to Johnson's testosterone levels.

Why the Distinction Matters to Patients

Patients reading celebrity TRT stories frequently present to telehealth and in-person clinics citing those stories as motivation for self-diagnosis. A 2022 survey published in JAMA Internal Medicine found that 35% of men who initiated TRT did so without meeting the two-morning-draw threshold for confirmed hypogonadism 8. TRT carries real cardiovascular and fertility risks. The FDA mandates a boxed warning on all testosterone products regarding potential cardiovascular events and abuse potential 5.

Responsible Clinical Framing

The correct clinical sequence for any man wondering about TRT is straightforward. A morning serum total testosterone test (drawn between 7 and 10 a.m.) paired with LH, FSH, SHBG, and CBC should precede any prescription. A second confirmatory draw at least one week later is required by Endocrine Society guidelines before initiating therapy 2. Celebrity physique comparisons are not diagnostic criteria.

Adolescent Steroid Use and Long-Term Hormonal Health

Johnson's admission of teenage steroid use raises a medically relevant question independent of his current status. What are the documented long-term hormonal consequences of adolescent anabolic-androgenic steroid (AAS) exposure?

HPG Axis Suppression

AAS use suppresses endogenous testosterone production via negative feedback on the HPG axis. In adolescents whose HPG axis is still maturing, this suppression may be prolonged or, in some cases, persist into adulthood. A study published in Frontiers in Endocrinology (2020, N=62 former AAS users) found that 18 months after cessation, 41% still showed below-normal LH pulsatility 9. Recovery was slower in men who initiated use before age 21.

Bone and Growth Plate Effects

Premature closure of growth plates is a documented risk of AAS exposure before epiphyseal fusion 10. Johnson stands 6 feet 5 inches tall, which argues against significant growth plate compromise, but bone density trajectories in former adolescent AAS users remain an active area of study.

Implications for Adult TRT Eligibility

A man with a documented history of adolescent AAS use and current biochemically confirmed hypogonadism is a medically appropriate TRT candidate under Endocrine Society criteria, provided the HPG axis has not recovered spontaneously. Prior AAS use does not disqualify a patient from TRT; it may, in fact, be a causal factor supporting the diagnosis.

Comparing Johnson's Situation to Published TRT Clinical Profiles

A 52-year-old male with decades of high-intensity resistance training, a history of adolescent AAS use, and a demanding professional schedule involving sleep disruption and caloric cycling represents a clinical profile that many sports medicine physicians would consider worth screening for hypogonadism.

Testosterone and Aging Data

The Baltimore Longitudinal Study of Aging found mean total testosterone declined approximately 0.4% per year in men after age 35 11. By age 52, a man who had 700 ng/dL at age 35 might expect levels near 580 ng/dL on average, though individual variance is wide. Athletes with high training volumes and low body fat often have lower baseline testosterone than sedentary peers.

Body Composition Context

Johnson has publicly stated his training involves two-a-day sessions during film preparation, with meals exceeding 5,000 calories for muscle-building phases. Extreme caloric restriction and very high training volumes can suppress testosterone through elevated cortisol and reduced LH pulsatility 12. This physiological reality applies whether or not TRT is in use.

What Responsible Telehealth TRT Evaluation Looks Like

For men 40 and older who follow Johnson's public story and wonder about their own testosterone levels, a structured evaluation path is available.

Step One: Symptom Inventory

The Androgen Deficiency in Aging Males (ADAM) questionnaire, validated in a 2000 study in Urology (sensitivity 88%, specificity 60%), asks ten questions covering libido, energy, strength, mood, and erectile function 13. A positive screen (answer "yes" to questions 1 or 7, or any 3 others) warrants bloodwork, not a prescription.

Step Two: Biochemical Confirmation

Two morning total testosterone draws on separate days, both below 300 ng/dL, are required for diagnosis. Free testosterone calculation using SHBG is appropriate in obese men or those with altered SHBG binding. The Endocrine Society's 2018 guideline specifies equilibrium dialysis or calculated free testosterone as acceptable methods 2.

Step Three: Shared Decision-Making on Therapy

Once confirmed, the choice of delivery method depends on patient preference, fertility goals, and adherence likelihood. Men wishing to preserve fertility should know that exogenous testosterone suppresses spermatogenesis. The American Urological Association recommends clomiphene citrate or hCG-based protocols for hypogonadal men seeking to maintain sperm production 14.